Felypressin
As of the edition of 20 October 2026, Felypressin is a protein: marketed; acts on AVPR1A.
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Marketed
- Kind
- Protein
- Brand name
- Citanest
- Approvals on record
- 8 in 8 regions
- Holder of the most recent approval
- Dentsply Detrey; 2 holders in all
US protection
No US approval on record.
With no US approval on record there are no listed US patents or exclusivities.
This is the US only.
Target
| Gene | Protein | UniProt |
|---|---|---|
| AVPR1A | Vasopressin V1a receptor | P37288 |